Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -154.34% is 16% above its 5-year average of -184.63%, near the high end of its 5-year range (-387.38%–-64.05%).
32.08% above its 12-month average of -227.23%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -33.92%.
RETURN ON ASSETS (ROA)
-154.34%
RETURN ON ASSETS (ROA) AVG TTM
-227.23%
RETURN ON ASSETS (ROA) AVG 3Y
-240.86%
RETURN ON ASSETS (ROA) AVG 5Y
-184.63%
RETURN ON ASSETS (ROA) AVG 10Y
-150.24%
RETURN ON ASSETS (ROA) AVG 15Y
-111.87%
RETURN ON ASSETS (ROA) AVG 20Y
-111.53%
CURRENT VS TTM AVG
+32.08%
CURRENT VS 3Y AVG
+35.92%
CURRENT VS 5Y AVG
+16.41%
CURRENT VS 10Y AVG
-2.73%
CURRENT VS 15Y AVG
-37.97%
CURRENT VS 20Y AVG
-38.39%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-378.72%
vs the sector median at left
BioCardia, Inc.
Market Cap
$15.78M
Return on Assets (ROA)
-154.34%
TTM Avg
-227.23%
3Y Avg
-240.86%
5Y Avg
-184.63%
Market Cap
$15.68M
Return on Assets (ROA)
-38.41%
TTM Avg
-84.87%
3Y Avg
-95.12%
5Y Avg
-75.66%
Market Cap
$15.54M
Return on Assets (ROA)
2.23%
TTM Avg
5.13%
3Y Avg
7.99%
5Y Avg
9.09%
Market Cap
$14.96M
Return on Assets (ROA)
-201.89%
TTM Avg
-113.65%
3Y Avg
-83.24%
5Y Avg
-72.72%
Market Cap
$15.24M
Return on Assets (ROA)
-213.77%
TTM Avg
-110.51%
3Y Avg
-93.41%
5Y Avg
-68.22%
Market Cap
$16.43M
Return on Assets (ROA)
-116.60%
TTM Avg
-66.28%
3Y Avg
-71.56%
5Y Avg
-63.10%
Market Cap
$16.56M
Return on Assets (ROA)
-68.66%
TTM Avg
-45.54%
3Y Avg
-39.28%
5Y Avg
-39.25%
Market Cap
$16.64M
Return on Assets (ROA)
-67.58%
TTM Avg
-90.98%
3Y Avg
-83.38%
5Y Avg
-70.12%
Market Cap
$15.03M
Return on Assets (ROA)
-41.18%
TTM Avg
-60.23%
3Y Avg
-53.11%
5Y Avg
-40.22%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCardia, Inc. (BCDA) | $15.78M | -154.34% | -227.23% | -240.86% | -184.63% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | -38.41% | -84.87% | -95.12% | -75.66% |
| Jin Medical International Ltd. (ZJYL)vs › | $15.54M | 2.23% | 5.13% | 7.99% | 9.09% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.96M | -201.89% | -113.65% | -83.24% | -72.72% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.24M | -213.77% | -110.51% | -93.41% | -68.22% |
| Dyadic International, Inc. (DYAI)vs › | $16.43M | -116.60% | -66.28% | -71.56% | -63.10% |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.56M | -68.66% | -45.54% | -39.28% | -39.25% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -67.58% | -90.98% | -83.38% | -70.12% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.03M | -41.18% | -60.23% | -53.11% | -40.22% |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | -98.29% | -314.03% | -259.71% | -198.18% |
ROA
-154.3%
ROE
-271.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -241.08% |
| 2024-12-31 | -213.37% |
| 2023-12-31 | -387.38% |
| 2022-12-31 | -121.59% |
| 2021-12-31 | -80.30% |
| 2020-12-31 | -64.05% |
| 2019-12-31 | -191.57% |
| 2018-12-31 | -217.97% |
| 2017-12-31 | -90.91% |
| 2016-12-31 | -46.69% |
| 2015-12-31 | 2.32% |
| 2014-12-31 | 1.73% |
| 2013-12-31 | 0.14% |
| 2012-12-31 | 2.29% |
| 2011-12-31 | 70.35% |
| 2010-12-31 | -211.76% |
| 2009-12-31 | -32.58% |
| 2008-12-31 | -50.55% |
| 2008-06-30 | -329.47% |
| 2007-06-30 | -86.61% |
| 2006-06-30 | -53.06% |
| 2005-06-30 | -90.50% |
| 2004-06-30 | -42.38% |
| 2003-06-30 | -18.17% |
| 2002-06-30 | -41.43% |
| 2001-06-30 | -52.04% |
| 2000-06-30 | -20.78% |
| 1999-06-30 | -40.62% |
| 1998-06-30 | -14.63% |
| 1997-06-30 | -12.77% |
